GridAI Technologies (GRDX) Enterprise Value (2025 - 2026)
GridAI Technologies' (GRDX) quarterly Enterprise Value came in at $35.8 million in Q2 2026, up 204.71% quarter-over-quarter from $11.8 million in Q4 2025.
Powered by 
Analysis
GridAI Technologies (GRDX) Enterprise Value (2025 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Enterprise Value for 2 consecutive years, with $35.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Enterprise Value changed N/A year-over-year to $35.8 million; the trailing twelve-month figure through Jun 2026 stood at $35.8 million (changed N/A YoY), and the FY2025 full-year result was $11.8 million, changed N/A from the prior year.
- Enterprise Value improved to $35.8 million in Q2 2026 per GRDX's latest filing, from $11.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at $35.8 million in Q2 2026 and bottomed at $11.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 |